
Delia M. Ramirez
Examiner (ID: 4462)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1518 |
| Issued Applications | 818 |
| Pending Applications | 200 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17953684
[patent_doc_number] => 11479778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Construction of accumulating
[patent_app_type] => utility
[patent_app_number] => 17/285816
[patent_app_country] => US
[patent_app_date] => 2020-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 3845
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285816 | Construction of accumulating | Nov 29, 2020 | Issued |
Array
(
[id] => 17258948
[patent_doc_number] => 20210371933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => COMPOSITIONS FOR DETECTING MUTANT ANAPLASTIC LYMPHOMA KINASE IN LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 17/102639
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102639
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102639 | Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer | Nov 23, 2020 | Issued |
Array
(
[id] => 16657786
[patent_doc_number] => 20210054422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/091599
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091599 | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds | Nov 5, 2020 | Issued |
Array
(
[id] => 16824580
[patent_doc_number] => 20210139873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => RNA SILENCING NANOZYMES
[patent_app_type] => utility
[patent_app_number] => 17/091735
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091735
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091735 | RNA silencing nanozymes | Nov 5, 2020 | Issued |
Array
(
[id] => 16808251
[patent_doc_number] => 20210130804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => KNOCKOUT OF A MUTANT ALLELE OF AN ELANE GENE
[patent_app_type] => utility
[patent_app_number] => 17/090814
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090814 | Method to inactivate a mutant allele of an | Nov 4, 2020 | Issued |
Array
(
[id] => 18620634
[patent_doc_number] => 11753662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Method for producing 3-Oxoadipic acid
[patent_app_type] => utility
[patent_app_number] => 17/088701
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10856
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/088701 | Method for producing 3-Oxoadipic acid | Nov 3, 2020 | Issued |
Array
(
[id] => 17742839
[patent_doc_number] => 11390896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Method for producing L-methionine using a bacterium of the genus
[patent_app_type] => utility
[patent_app_number] => 17/081626
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10740
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/081626 | Method for producing L-methionine using a bacterium of the genus | Oct 26, 2020 | Issued |
Array
(
[id] => 18739902
[patent_doc_number] => 20230348869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => MAD7 NUCLEASE IN PLANTS AND EXPANDING ITS PAM RECOGNITION CAPABILITY
[patent_app_type] => utility
[patent_app_number] => 17/768635
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768635 | MAD7 NUCLEASE IN PLANTS AND EXPANDING ITS PAM RECOGNITION CAPABILITY | Oct 13, 2020 | Pending |
Array
(
[id] => 16583156
[patent_doc_number] => 20210017558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/061741
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061741 | Metabolically engineered organisms for the production of added value bio-products | Oct 1, 2020 | Issued |
Array
(
[id] => 19311776
[patent_doc_number] => 12037579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Synthetic RNA binding polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/029666
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 32
[patent_no_of_words] => 30035
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17029666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/029666 | Synthetic RNA binding polypeptides | Sep 22, 2020 | Issued |
Array
(
[id] => 18329510
[patent_doc_number] => 11634739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Regulation method for preparing g-polyglutamic acid by sludge substrate fermentation
[patent_app_type] => utility
[patent_app_number] => 17/027732
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2628
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 363
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17027732
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/027732 | Regulation method for preparing g-polyglutamic acid by sludge substrate fermentation | Sep 21, 2020 | Issued |
Array
(
[id] => 18077784
[patent_doc_number] => 20220403396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHODS AND COMPOSITIONS FOR DNA BASE EDITING
[patent_app_type] => utility
[patent_app_number] => 17/763384
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763384 | METHODS AND COMPOSITIONS FOR DNA BASE EDITING | Sep 17, 2020 | Pending |
Array
(
[id] => 18077784
[patent_doc_number] => 20220403396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHODS AND COMPOSITIONS FOR DNA BASE EDITING
[patent_app_type] => utility
[patent_app_number] => 17/763384
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763384 | METHODS AND COMPOSITIONS FOR DNA BASE EDITING | Sep 17, 2020 | Pending |
Array
(
[id] => 16557529
[patent_doc_number] => 20210002677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => SYNTHESIS OF OMEGA FUNCTIONALIZED PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/021338
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021338
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021338 | SYNTHESIS OF OMEGA FUNCTIONALIZED PRODUCTS | Sep 14, 2020 | Abandoned |
Array
(
[id] => 16656014
[patent_doc_number] => 20210052650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
[patent_app_type] => utility
[patent_app_number] => 17/016056
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016056 | Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene | Sep 8, 2020 | Issued |
Array
(
[id] => 16506512
[patent_doc_number] => 20200385768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/002671
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/002671 | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds | Aug 24, 2020 | Issued |
Array
(
[id] => 16513212
[patent_doc_number] => 20200392470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => NOVEL ACYLTRANSFERASES, VARIANT THIOESTERASES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/998268
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998268 | NOVEL ACYLTRANSFERASES, VARIANT THIOESTERASES, AND USES THEREOF | Aug 19, 2020 | Abandoned |
Array
(
[id] => 17060128
[patent_doc_number] => 11104715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
[patent_app_type] => utility
[patent_app_number] => 16/996030
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 67372
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996030 | Methods for producing aflibercept in chemically defined media having reduced aflibercept variants | Aug 17, 2020 | Issued |
Array
(
[id] => 16557470
[patent_doc_number] => 20210002618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF ARMODAFINIL
[patent_app_type] => utility
[patent_app_number] => 16/995444
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16995444
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/995444 | Biocatalysts and methods for the synthesis of armodafinil | Aug 16, 2020 | Issued |
Array
(
[id] => 17852184
[patent_doc_number] => 20220282226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MODIFIED HOST CELLS FOR HIGH EFFICIENCY PRODUCTION OF VANILLIN
[patent_app_type] => utility
[patent_app_number] => 17/631429
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631429 | Modified host cells for high efficiency production of vanillin | Jul 30, 2020 | Issued |